PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Adler, Caleb
TI  - Armodafinil Shows Potential Benefit for Depressive Symptoms in Bipolar Disorder
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 12--13
VI  - 14
IP  - 8
4099  - http://mdc.sagepub.com/content/14/8/12.short
4100  - http://mdc.sagepub.com/content/14/8/12.full
AB  - Armodafinil 150 mg daily for 8 weeks as an adjuvant with mood stabilizers and/or antipsychotic drugs improved depressive symptoms associated with bipolar I disorder. The benefits, however, were not statistically significant compared with placebo. The findings of a multi-institutional, international, Phase 3, randomized, double-blind, placebo-controlled trial are discussed in this article [APA 2014 (poster NR6-038); NCT01305408].